vs

Side-by-side financial comparison of Caesarstone Ltd. (CSTE) and Inogen Inc (INGN). Click either name above to swap in a different company.

Caesarstone Ltd. is the larger business by last-quarter revenue ($94.4M vs $68.6M, roughly 1.4× Inogen Inc). Inogen Inc produced more free cash flow last quarter ($-1.9M vs $-47.1M). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs -57.8%).

Caesarstone Ltd., is a publicly traded company that engages in the production and marketing of quartz, porcelain, mineral and advanced fusion surfaces used for kitchen countertops, vanity tops, flooring, wall cladding and general interior design. The company was founded in 1987 and is traded on the NASDAQ in New York (CSTE). Headquarters are located in Kibbutz Sdot Yam in Israel. Production facilities are in Israel and India with third party manufactured product sourced from factories in the ...

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

CSTE vs INGN — Head-to-Head

Bigger by revenue
CSTE
CSTE
1.4× larger
CSTE
$94.4M
$68.6M
INGN
More free cash flow
INGN
INGN
$45.1M more FCF
INGN
$-1.9M
$-47.1M
CSTE
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
-57.8%
CSTE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CSTE
CSTE
INGN
INGN
Revenue
$94.4M
$68.6M
Net Profit
$-87.9M
Gross Margin
15.5%
51.4%
Operating Margin
-87.2%
-13.6%
Net Margin
-93.1%
Revenue YoY
3.4%
Net Profit YoY
EPS (diluted)
$-2.55
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSTE
CSTE
INGN
INGN
Q4 25
$94.4M
$68.6M
Q3 25
$345.4M
$79.1M
Q2 25
$237.7M
$79.2M
Q1 25
$68.5M
Q4 24
$66.3M
Q3 24
$436.7M
$74.9M
Q2 24
$294.3M
$74.4M
Q1 24
$150.6M
$63.1M
Net Profit
CSTE
CSTE
INGN
INGN
Q4 25
$-87.9M
Q3 25
$-18.5M
$-5.3M
Q2 25
$-14.3M
$-4.2M
Q1 25
$-6.2M
Q4 24
Q3 24
$-57.4M
$-6.0M
Q2 24
$-56.6M
$-5.6M
Q1 24
$-3.9M
$-14.6M
Gross Margin
CSTE
CSTE
INGN
INGN
Q4 25
15.5%
51.4%
Q3 25
22.5%
52.2%
Q2 25
23.7%
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
15.7%
55.2%
Q2 24
14.1%
57.4%
Q1 24
19.7%
54.5%
Operating Margin
CSTE
CSTE
INGN
INGN
Q4 25
-87.2%
-13.6%
Q3 25
-5.5%
-9.0%
Q2 25
-6.2%
-7.7%
Q1 25
-11.2%
Q4 24
-17.2%
Q3 24
-12.6%
-10.4%
Q2 24
-18.0%
-9.5%
Q1 24
-3.9%
-25.8%
Net Margin
CSTE
CSTE
INGN
INGN
Q4 25
-93.1%
Q3 25
-5.4%
-6.7%
Q2 25
-6.0%
-5.2%
Q1 25
-9.0%
Q4 24
Q3 24
-13.1%
-8.0%
Q2 24
-19.2%
-7.5%
Q1 24
-2.6%
-23.1%
EPS (diluted)
CSTE
CSTE
INGN
INGN
Q4 25
$-2.55
$-0.26
Q3 25
$-0.54
$-0.20
Q2 25
$-0.41
$-0.15
Q1 25
$-0.25
Q4 24
$-0.41
Q3 24
$-1.67
$-0.25
Q2 24
$-1.64
$-0.24
Q1 24
$-0.11
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSTE
CSTE
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$58.4M
$103.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$139.2M
$192.2M
Total Assets
$398.4M
$298.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSTE
CSTE
INGN
INGN
Q4 25
$58.4M
$103.7M
Q3 25
$106.5M
Q2 25
$103.7M
Q1 25
$118.9M
Q4 24
$113.8M
Q3 24
$105.7M
Q2 24
$97.9M
Q1 24
$107.4M
Total Debt
CSTE
CSTE
INGN
INGN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$-12.6M
Stockholders' Equity
CSTE
CSTE
INGN
INGN
Q4 25
$139.2M
$192.2M
Q3 25
$271.6M
$197.2M
Q2 25
$271.6M
$199.5M
Q1 25
$198.0M
Q4 24
$173.9M
Q3 24
$315.1M
$185.4M
Q2 24
$315.1M
$187.6M
Q1 24
$315.1M
$191.9M
Total Assets
CSTE
CSTE
INGN
INGN
Q4 25
$398.4M
$298.6M
Q3 25
$549.0M
$307.0M
Q2 25
$549.0M
$312.0M
Q1 25
$308.4M
Q4 24
$296.2M
Q3 24
$579.9M
$306.2M
Q2 24
$579.9M
$308.9M
Q1 24
$579.9M
$315.6M
Debt / Equity
CSTE
CSTE
INGN
INGN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSTE
CSTE
INGN
INGN
Operating Cash FlowLast quarter
$-38.0M
$-943.0K
Free Cash FlowOCF − Capex
$-47.1M
$-1.9M
FCF MarginFCF / Revenue
-49.8%
-2.8%
Capex IntensityCapex / Revenue
9.6%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$38.6M
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSTE
CSTE
INGN
INGN
Q4 25
$-38.0M
$-943.0K
Q3 25
$35.0M
$2.2M
Q2 25
$18.7M
$4.3M
Q1 25
$-16.8M
Q4 24
$-3.0M
Q3 24
$53.3M
$7.0M
Q2 24
$25.1M
$6.7M
Q1 24
$7.9M
$-4.7M
Free Cash Flow
CSTE
CSTE
INGN
INGN
Q4 25
$-47.1M
$-1.9M
Q3 25
$26.7M
$1.6M
Q2 25
$14.3M
$3.7M
Q1 25
$-17.1M
Q4 24
$-3.3M
Q3 24
$44.6M
$5.3M
Q2 24
$20.7M
$6.6M
Q1 24
$5.0M
$-6.1M
FCF Margin
CSTE
CSTE
INGN
INGN
Q4 25
-49.8%
-2.8%
Q3 25
7.7%
2.0%
Q2 25
6.0%
4.6%
Q1 25
-24.9%
Q4 24
-5.0%
Q3 24
10.2%
7.1%
Q2 24
7.0%
8.9%
Q1 24
3.3%
-9.6%
Capex Intensity
CSTE
CSTE
INGN
INGN
Q4 25
9.6%
1.4%
Q3 25
2.4%
0.7%
Q2 25
1.8%
0.9%
Q1 25
0.4%
Q4 24
0.5%
Q3 24
2.0%
2.2%
Q2 24
1.5%
0.1%
Q1 24
1.9%
2.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSTE
CSTE

America's$53.0M56%
USA$41.4M44%

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons